|
⚲
|
| Keyboard |
| BCLS II Investco LP
✚
|
|
|---|---|
| CIK # | 0001818893 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-NT | [0001818893] | |
| 3 | [0001818893] | |
| 4 | [0001818893] | |
| SC 13D | [0001818893] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| BCLS II Investco LP | Newamsterdam Pharma Co NV | [2022-12-02] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Solid Biosciences Inc SLDB
Pre-Funded Warrant (right to buy) · derivative
|
2025-02-19 | Buy | 6,444,170 | $4.03 | 25,970,005 |
|
Solid Biosciences Inc SLDB
Common Stock
|
2025-02-19 | Buy | 1,000,000 | $4.03 | 4,030,000 |
|
NewAmsterdam Pharma Co NV NAMS
Pre-Funded Warrant (right to buy) · derivative
|
2024-12-13 | Buy | 1,632,653 | $24.50 | 39,999,998 |
|
Solid Biosciences Inc SLDB
Common Stock
|
2024-01-11 | Grant | 904,160 | $5.53 | 5,000,005 |
|
Xilio Therapeutics Inc XLO
Common Stock
|
2021-12-10 | Buy | 21,812 | $9.56 | 208,523 |
|
Xilio Therapeutics Inc XLO
Common Stock
|
2021-12-10 | Buy | 3,188 | $10.24 | 32,645 |
|
Xilio Therapeutics Inc XLO
Common Stock
|
2021-12-09 | Buy | 4,011 | $9.84 | 39,468 |
|
Xilio Therapeutics Inc XLO
Common Stock
|
2021-12-08 | Buy | 13,458 | $9.62 | 129,466 |